Tracking your data after you stop GLP-1 medication

Once you move off medication, GLPath's dashboard shifts to what's still relevant: a band-position gauge instead of a dose chart, weight-focused widgets in place of the ones built around active dosing, and the same weight and BMI history you've had all along, still there to look back over. Nothing about the record stops mattering just because the dose log stops growing — it's simply read differently from here.

What replaces the dose chart once you're off medication?

With no doses being logged, the dose step-chart naturally has nothing new to add, so the dashboard leans on a band-position gauge instead — a neutral, slate-colored read of where your current weight sits relative to the range it settled into. It isn't a pass-or-fail indicator and it isn't colored to suggest one; GLPath's design deliberately keeps this kind of data calm rather than alarming, the same way it treats every other phase.

Why does the dashboard show fewer widgets in this phase?

Off-medication tracking narrows to weight-only widgets rather than carrying forward every tile from earlier phases, because most of what those other tiles measured — a dose step, a medication-specific side-effect list — has nothing current to show. That's a deliberate simplification, not a downgrade: the dashboard shows what's actually relevant to where you are rather than empty tiles left over from an earlier phase. Everything logged during earlier phases stays exactly where it was, still visible in the journey timeline and still exportable.

Does the record still matter if you're not actively dosing?

Yes — arguably more than during any single phase, because it's the only place the whole arc lives in one view. If you're considering a restart, or just want to understand how your weight has held since stopping, the record of what happened during active dosing, through tapering, and since is what makes that a concrete question rather than a guess based on memory. The tapering guide covers what the same charts looked like on the way down, which is often the most useful stretch to compare against once you're off medication.

What's worth bringing to a clinician during this phase?

A neutral band-position reading, a weight trend that's held steady or drifted, and a full history of the phases and doses that led here are exactly the kind of concrete facts that make a "should I consider restarting" conversation more useful than one built on memory alone. GLPath doesn't answer that question — it isn't trying to — but if your band position has shifted noticeably since stopping, that's a pattern worth discussing with your clinician rather than something to sit with unspoken until your next appointment happens to come up.

Where does this data actually live, and can you take it with you?

Nothing about being off medication changes how the data belongs to you. Every weight entry, phase marker, and dose you logged while on medication is still yours to export as CSV, generate into a PDF report, or pull entirely through Takeout — the your-data-is-yours guide covers exactly what that looks like in practice. The record doesn't end when the dosing does; it's the same account, the same history, just read through a different lens for whatever comes next.